Table 3.
Variable | UTI/Number (%) | Crude odds ratio (95% CI) | Adjusted odds ratio (95%CI)** |
---|---|---|---|
Sex | |||
Male | 74/2,527 (2.9) | 1 | |
Female | 32/1,350 (2.4) | 0.79 (0.52–1.20) | _________________ |
CV line | |||
No | 78/3,445 (2.3) | 1 | |
Yes | 27/341 (7.9) | 3.75 (2.37–5.92) | 1.10 (0.53–2.27) |
Missing | 1/91 (0.01) | ||
Steroids | |||
No | 54/2,808 (1.9) | 1 | |
Yes | 51/975 (5.2) | 3.76 (1.70–8.32) | 1.90 (1.08–3.32) |
Missing | 1/94 (0.01) | ||
CD4 (cells/ul) | |||
<200 | 24/654 (3.7) | 1 | |
≥200 | 36/1,308 (2.8) | 0.73 (0.42–1.25) | _________________ |
Missing | 1,915 | ||
ARV | |||
No | 78/3,140 (2.5) | 1 | |
Yes | 28/737 (3.8) | 1.5.4 (0.99–2.40) | _________________ |
TMP-SMX | |||
No | 7/546(1.3) | 1 | |
Yes | 62/1,336 (4.6) | 3.49 (1.76–6.91) | 3.19 (1.41–7.22) |
Missing | 1995 | ||
Length of staya | ________________ | 1.04 (1.02–1.05) | 1.01 (0.99–1.03) |
Agea | ________________ | 1.00 (0.98–1.02) | _________________ |
Continuous variable
Adjusted for all significant univariable predictors and renal failure
ARV: antiretroviral agents; UTI: urinary tract infection; TMP-SMX: trimethoprim-sulphamethoxazole